The efficiency of citalopram in preserving an antidepressant feedback for as much as 24 weeks complying with 6 to 8 weeks of acute treatment was shown in 2 placebo-controlled trials (view CLINICAL PHARMACOLOGY).

All stated occasions are included other than those already provided in TABLE 3 or elsewhere in labeling, those events for which a drug cause was remote, those event terms which were so basic regarding be uninformative, and also those happening in only one client.

Clients, their family members, and their caregivers ought to be encouraged to be alert to the development of stress and anxiety, anxiety, panic attacks, insomnia, impatience, hostility, aggression, impulsivity, akathisia (psychomotor restlessness), hypomania, mania, other unusual modifications in actions, getting worse of depression, and also self-destructive ideation, particularly early during antidepressant therapy and also when the dose is readjusted up or down.

TABLE 3 specifies the occurrence, rounded to the local percent, of treatment-emergent negative events that took place amongst 1, 063 depressed people that obtained citalopram at doses varying from 10 to 80 mg/day in placebo-controlled tests of around 6 weeks in duration.